March 29, 2023 - April 3, 2023

Sotac Pharmaceuticals IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Sotac Pharmaceuticals IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Sotac Pharmaceuticals IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Sotac Pharmaceuticals IPO Review by Dilip Davda (Avoid)

[Dilip Davda] This pharma/healthcare segment company has marked wild fluctuations in its bottom lines for the reported periods. Based on FY23 annualized earnings, the issue appears exorbitantly priced. It is operating in a highly competitive and fragmented segment. SPL’s debt level is also higher and raises concerns. There is no harm in skipping this pricey bet. Read detail review...

Sotac Pharmaceuticals IPO Review by Members

Sotac Pharmaceuticals IPO Reviews, analysis and views by popular members. Read Sotac Pharmaceuticals Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Sotac Pharmaceuticals IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	2	0	0	1
%	66.67	0.00	0.00	33.33

Member	Review
SANKETKP	Apply for Long Term at Upper Price Band Having good clients and Long term growth benefits to customer and company. March 24, 2023 10:45:55 AM
mayank vadaliya	Apply for Listing Gain at Upper Price Band good to invest looking from balance sheet. i heard name of company have good image in pharma works. March 24, 2023 10:48:09 AM
CAhsBlr	Avoid Avoid. 1. Promotor holding not specified. 2. Sudden spike in Profit and again big dip. 3. Huge increase in borrowings. March 24, 2023 12:21:25 PM

Member

Review

SANKETKP

Apply for Long Term at Upper Price Band

Having good clients and Long term growth benefits to customer and company.

March 24, 2023 10:45:55 AM

mayank vadaliya

Apply for Listing Gain at Upper Price Band

good to invest looking from balance sheet.
i heard name of company have good image in pharma works.

March 24, 2023 10:48:09 AM

CAhsBlr

Avoid

Avoid.

1. Promotor holding not specified.
2. Sudden spike in Profit and again big dip.
3. Huge increase in borrowings.

March 24, 2023 12:21:25 PM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.